<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC7293477/table_2" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 2</label>
  <p>vaccine candidates based on RNA platform for COVID-19 according to the WHO as of April 20, 2020 (adapted from (20).</p>
 </caption>
 <thead>
  <tr>
   <th align="left" colspan="1" rowspan="1" id="0-0-.">Type of candidate vaccine</th>
   <th align="left" colspan="1" rowspan="1" id="0-1-.">developer</th>
   <th align="left" colspan="1" rowspan="1" id="0-2-.">stage of clinical evaluation</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td align="left">LNP-encapsulated mRNA(mRNA-1273)</td>
   <td align="left">
    <br/>USA (Moderna/NIAI) 
   </td>
   <td align="left">Phase 2 
    <br/>(NCT04283461) 
   </td>
  </tr>
  <tr>
   <td align="left">LNP-encapsulated mRNA cocktail encoding VLP</td>
   <td align="left">Fudan University/ Shanghai JiaoTong University/RNACure Biopharma</td>
   <td align="left">preclinical</td>
  </tr>
  <tr>
   <td align="left">mRNA</td>
   <td align="left">China CDC/Tongji University/Stermina</td>
   <td align="left">preclinical</td>
  </tr>
  <tr>
   <td align="left">mRNA</td>
   <td align="left">Arcturus/Duke-NU</td>
   <td align="left">preclinical</td>
  </tr>
  <tr>
   <td align="left">mRNA</td>
   <td align="left">BioNTech/Fosun Pharma/Pfizer</td>
   <td align="left">preclinical</td>
  </tr>
  <tr>
   <td align="left">saRNA</td>
   <td align="left">Imperial College London</td>
   <td align="left">preclinical</td>
  </tr>
  <tr>
   <td align="left">mRNA</td>
   <td align="left">Curevac</td>
   <td align="left">preclinical</td>
  </tr>
 </tbody>
</table>
